Plant-parasitic nematodes trigger intensive annual yield losses to worldwide agricultural manufacturing. Most cultivated vegetation haven’t any recognized resistance in opposition to nematodes and the few bearing a resistance gene may be overcome by sure species.
Chemical strategies which were deployed to manage nematodes have largely been banned from use as a consequence of their poor specificity and excessive toxicity. Therefore, there may be an pressing want for the event of cleaner and extra particular management strategies.
Current advances in nematode genomics, together with in phytoparasitic species, present an unprecedented alternative to establish genes and features particular to those pests. Utilizing phylogenomics, we in contrast 61 nematode genomes, together with 16 for plant-parasitic species and recognized greater than 24,000 protein households particular to those parasites. Within the genome of Meloidogyne incognita, probably the most devastating plant parasites, we discovered ca. 10,000 proteins with orthologs restricted solely to phytoparasitic species and no additional homology in protein databases.
Amongst these phytoparasite-specific proteins, ca. 1000 shared the identical properties as recognized secreted effectors concerned in important parasitic features. Of those, 68 have been novel and confirmed sturdy expression throughout the endophytic section of the nematode life cycle, based mostly on each RNA-seq and RT-qPCR analyses. In addition to effector candidates, transcription-related and neuro-perception features have been enriched in phytoparasite-specific proteins, revealing fascinating targets for nematode management strategies. This phylogenomics evaluation constitutes a singular useful resource for the additional understanding of the genetic foundation of nematode adaptation to phytoparasitism and for the event of extra environment friendly management strategies.
Genomic Range and Evolution of Quasispecies in Newcastle Illness Virus Infections
Newcastle illness virus (NDV) infections are well-known to harbour quasispecies, as a result of error-prone nature of the RNA polymerase. Quasispecies variants within the fusion cleavage web site of the virus are recognized to considerably change its virulence. Nevertheless, little is understood concerning the genomic patterns of variety and choice in NDV viral swarms. We analyse deep sequencing information from in vitro and in vivo NDV infections to uncover the genomic patterns of variety and the signatures of choice inside NDV swarms.
Variants in viruses from in vitro samples are principally localised in non-coding areas and three’ and 5′ untranslated areas (3’UTRs or 5’UTRs), whereas in vivo samples include an order of magnitude extra variants. We discover completely different patterns of genomic divergence and variety amongst NDV genotypes, in addition to variations within the genomic distribution of intra-host variants amongst in vitro and in vivo infections of the identical pressure.
The frequency spectrum reveals clear signatures of intra-host purifying choice in vivo on the matrix protein (M) coding gene and constructive or diversifying choice on nucleocapsid (NP) and haemagglutinin-neuraminidase (HN). The comparability between within-host polymorphisms and phylogenetic divergence reveals complicated patterns of selective stress on the NDV genome at between- and within-host stage. The M sequence is strongly constrained each between and inside hosts, fusion protein (F) coding gene is below intra-host constructive choice, and NP and HN present contrasting patterns: HN RNA sequence is positively chosen between hosts whereas its protein sequence is positively chosen inside hosts, and NP is below intra-host constructive choice on the RNA stage and damaging choice on the protein stage.
Inhabitants genomics reveal apomixis in a novel system: uniclonal feminine populations dominate the tropical forest herb household, Hanguanaceae (Commelinales)
The abundance of apomixis in tropical plant genera is poorly understood, and this impacts the understanding of speciation and evolution. Hanguanaceae is a tropical monogeneric, dioecious plant household. All however two species are solitary herbs with no functionality to unfold vegetatively. Viable seeds are sometimes produced when males haven’t been noticed. Our intention was to research the presence of apomixis in Hanguana.
We used decreased illustration genomics to review phylogenetics and genetic variability in all populations of Hanguana in Singapore. We measured genome sizes and estimated ploidy ranges in 10 species. Nearly all taxa examined have been genetically uniform (uniclonal) whatever the extent of their distribution. The distribution of single clones over distinct localities helps our speculation of apomictic replica.
Clostridium difficile |
PCR-VH005-PCRVH00596D |
Bioingentech |
PCR-VH005-96D |
EUR 312 |
Clostridium Difficile |
FD010-5VL |
EWC Diagnostics |
1 unit |
EUR 23.97 |
Description: Clostridium Difficile |
Clostridium difficile GDH |
5192 |
Virostat |
each |
EUR 270 |
Description: GDH |
Clostridium difficile GDH |
5193 |
Virostat |
each |
EUR 270 |
Description: GDH |
Clostridium difficile GDH |
5194 |
Virostat |
each |
EUR 270 |
Description: GDH |
Clostridium difficile GDH |
5195 |
Virostat |
each |
EUR 270 |
Description: GDH |
Clostridium difficile GDH |
5196 |
Virostat |
each |
EUR 270 |
Description: GDH |
Clostridium difficile antibody |
10-2724 |
Fitzgerald |
1 mg |
EUR 365 |
|
Description: Mouse monoclonal Clostridium difficile antibody (GDH specific) |
Clostridium difficile PCR kit |
PCR-VH005-48D |
Bioingentech |
50T |
EUR 543.6 |
Clostridium difficile PCR kit |
PCR-VH005-96D |
Bioingentech |
100T |
EUR 686.4 |
*Clostridium Difficile Supplement |
FD010-5X5VL |
EWC Diagnostics |
1 unit |
EUR 62.85 |
Description: *Clostridium Difficile Supplement |
Clostridium Difficile Toxin A |
CDA-TNL-100 |
The Native Antigen Company |
0.1 |
EUR 500.09 |
Description: Native toxin A purified from C. difficile. |
Clostridium Difficile Toxin A |
CDA-TNL-50 |
The Native Antigen Company |
0.05 |
EUR 284.5 |
Description: Native toxin A purified from C. difficile. |
Clostridium Difficile Toxin A |
CDA-TNL-500 |
The Native Antigen Company |
0.5 |
EUR 1908.52 |
Description: Native toxin A purified from C. difficile. |
Clostridium Difficile Toxin B |
CDB-TNL-100 |
The Native Antigen Company |
0.1 |
EUR 1497.73 |
Description: Native toxin B purified from C. difficile. |
Clostridium Difficile Toxin B |
CDB-TNL-50 |
The Native Antigen Company |
0.05 |
EUR 854.75 |
Description: Native toxin B purified from C. difficile. |
Clostridium Difficile Toxin B |
CDB-TNL-500 |
The Native Antigen Company |
0.5 |
EUR 5994.75 |
Description: Native toxin B purified from C. difficile. |
Clostridium difficile Toxin A (C. difficile toxA) Antibody |
abx411009-1ml |
Abbexa |
1 ml |
EUR 526.8 |
|
Clostridium difficile Toxin A (C. difficile toxA) Antibody |
abx414381-01mg |
Abbexa |
0.1 mg |
EUR 693.6 |
|
Clostridium difficile Toxin B (C. difficile toxB) Antibody |
abx414897-01mg |
Abbexa |
0.1 mg |
EUR 693.6 |
|
Clostridium difficile Toxin B (C. difficile toxB) Antibody |
abx414898-01mg |
Abbexa |
0.1 mg |
EUR 526.8 |
|
Clostridium difficile Toxin A (C. difficile toxA) Antibody |
abx411009-250g |
Abbexa |
250 µg |
EUR 350 |
Clostridium difficile Toxin A (C. difficile toxA) Antibody |
abx414381-200l |
Abbexa |
200 µl |
EUR 487.5 |
Clostridium difficile Toxin B (C. difficile toxB) Antibody |
abx414897-200l |
Abbexa |
200 µl |
EUR 487.5 |
Clostridium difficile Toxin B (C. difficile toxB) Antibody |
abx414898-200l |
Abbexa |
200 µl |
EUR 687.5 |
Clostridium difficile Toxoid A |
abx670094-50ug |
Abbexa |
50 ug |
EUR 1262.4 |
|
Clostridium difficile Toxoid B |
abx670095-50ug |
Abbexa |
50 ug |
EUR 1262.4 |
|
Clostridium Difficile Toxoid A |
CDA-TDL-100 |
The Native Antigen Company |
0.1 |
EUR 500.09 |
Description: Native toxin A purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form. |
Clostridium Difficile Toxoid A |
CDA-TDL-50 |
The Native Antigen Company |
0.05 |
EUR 284.5 |
Description: Native toxin A purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form. |
Clostridium Difficile Toxoid A |
CDA-TDL-500 |
The Native Antigen Company |
0.5 |
EUR 1908.52 |
Description: Native toxin A purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form. |
Clostridium Difficile Toxoid B |
CDB-TDL-100 |
The Native Antigen Company |
0.1 |
EUR 1497.73 |
Description: Native toxin B purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form |
Clostridium Difficile Toxoid B |
CDB-TDL-50 |
The Native Antigen Company |
0.05 |
EUR 854.75 |
Description: Native toxin B purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form |
Clostridium Difficile Toxoid B |
CDB-TDL-500 |
The Native Antigen Company |
0.5 |
EUR 5600.54 |
Description: Native toxin B purified from C. difficile strain VPI10463 (toxinotype 0), converted to inactive toxoid form |
Clostridium Difficile Agar Base |
M836-500G |
EWC Diagnostics |
1 unit |
EUR 44.54 |
Description: Clostridium Difficile Agar Base |
Clostridium difficile Toxoid A |
abx670094-100g |
Abbexa |
100 µg |
EUR 987.5 |
Clostridium difficile Toxoid B |
abx670095-50g |
Abbexa |
50 µg |
EUR 1225 |
Clostridium difficile RT PCR kit |
RTq-VH005-100D |
Bioingentech |
100T |
EUR 860.4 |
Clostridium difficile RT PCR kit |
RTq-VH005-150D |
Bioingentech |
150T |
EUR 969.6 |
Clostridium difficile RT PCR kit |
RTq-VH005-50D |
Bioingentech |
50T |
EUR 717.6 |
Clostridium Difficile HiVeg Agar Base |
MV836-500G |
EWC Diagnostics |
1 unit |
EUR 44.54 |
Description: Clostridium Difficile HiVeg Agar Base |
Clostridium difficile Mannitol Taurochol |
M1976-500G |
EWC Diagnostics |
1 unit |
EUR 50.75 |
Description: Clostridium difficile Mannitol Taurochol |
Clostridium difficile Selective Suppleme |
FD320-5VL |
EWC Diagnostics |
1 unit |
EUR 37.25 |
Description: Clostridium difficile Selective Suppleme |
Clostridium difficile Toxin A protein |
30-1863 |
Fitzgerald |
10 ug |
EUR 568 |
|
Description: Purified Native Clostridium difficile Toxin A protein (ribotype 027) |
Clostridium difficile Toxin B protein |
30-1864 |
Fitzgerald |
10 ug |
EUR 654 |
|
Description: Purified Native Clostridium difficile Toxin B protein (ribotype 027) |
Clostridium difficile Toxin A protein |
30-1865 |
Fitzgerald |
10 ug |
EUR 682 |
|
Description: Purified Native Clostridium difficile Toxin A protein (ribotype 078) |
Clostridium difficile Toxin B protein |
30-1866 |
Fitzgerald |
10 ug |
EUR 870 |
|
Description: Purified Native Clostridium difficile Toxin B protein (ribotype 078) |
Clostridium Difficile Toxin A and B |
PCR-V039-PCRV03948D |
Bioingentech |
PCR-V039-48D |
EUR 230 |
Clostridium Difficile Toxin A and B |
PCR-V039-PCRV03996D |
Bioingentech |
PCR-V039-96D |
EUR 312 |
Clostridium Difficile Toxin A and B |
Oneq-V039-OneqV039100D |
Bioingentech |
Oneq-V039-100D |
EUR 515 |
Clostridium Difficile Toxin A and B |
Oneq-V039-OneqV039150D |
Bioingentech |
Oneq-V039-150D |
EUR 594 |
Clostridium Difficile Toxin A and B |
Oneq-V039-OneqV03950D |
Bioingentech |
Oneq-V039-50D |
EUR 413 |
Clostridium difficile Toxin A Antibody |
abx120033-1ml |
Abbexa |
1 ml |
EUR 1161.6 |
|
Clostridium difficile Toxin A Antibody |
abx120034-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
Clostridium difficile Toxin B Antibody |
abx120035-1ml |
Abbexa |
1 ml |
EUR 961.2 |
|
Clostridium difficile Toxin B Antibody |
abx120036-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
Clostridium difficile Toxin A Antibody |
abx021624-1mg |
Abbexa |
1 mg |
EUR 1629.6 |
|
Clostridium difficile Toxin A Antibody |
abx021625-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Clostridium difficile Toxin A Antibody |
abx021626-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Clostridium difficile Toxin A Antibody |
abx021627-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Clostridium difficile Toxin B Antibody |
abx021628-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Clostridium difficile Toxin B Antibody |
abx021629-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Clostridium difficile Toxin B Antibody |
abx021630-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Clostridium difficile Toxin B Antibody |
abx021631-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Clostridium difficile Toxin B Antibody |
abx021632-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Clostridium difficile toxin B antibody |
10-1274 |
Fitzgerald |
1 mg |
EUR 910 |
|
Description: Mouse monoclonal Clostridium difficile toxin B antibody |
Clostridium difficile toxin B antibody |
10-1276 |
Fitzgerald |
1 mg |
Ask for price |
|
Description: Mouse monoclonal Clostridium difficile toxin B antibody |
Clostridium difficile Toxin A antibody |
20-CR65 |
Fitzgerald |
1 mg |
EUR 242 |
|
Description: Rabbit polyclonal Clostridium difficile Toxin A antibody |
Clostridium difficile Toxoid A protein |
30-1861 |
Fitzgerald |
500 ug |
EUR 447 |
|
Description: Purified Native Clostridium difficile Toxoid A protein |
Clostridium difficile Toxoid B protein |
30-1862 |
Fitzgerald |
100 ug |
EUR 1246 |
|
Description: Purified Native Clostridium difficile Toxoid B protein |
Clostridium difficile Toxin A antibody |
70-1004 |
Fitzgerald |
500 ul |
EUR 347 |
|
Description: Goat polyclonal Clostridium difficile Toxin A antibody |
Clostridium difficile Toxin A antibody |
70-1005 |
Fitzgerald |
100 ug |
EUR 567 |
|
Description: Affinity purified Chicken polyclonal Clostridium difficile Toxin A antibody |
Clostridium difficile toxin B antibody |
70-1017 |
Fitzgerald |
100 ug |
EUR 600 |
|
Description: Affinity purified chicken polyclonal Clostridium difficile toxin B antibody |
Clostridium difficile toxin B antibody |
70-1095 |
Fitzgerald |
1 mg |
EUR 480 |
|
Description: Purified goat polyclonal Clostridium difficile toxin B antibody |
Clostridium difficile toxin A antibody |
70-1096 |
Fitzgerald |
1 mg |
EUR 848 |
|
Description: Purified goat polyclonal Clostridium difficile toxin A antibody |
Clostridium difficile Antibody (Toxin B) |
GWB-437919 |
GenWay Biotech |
1 mg |
Ask for price |
|
Clostridium difficile Antibody (Toxin A) |
GWB-46CB07 |
GenWay Biotech |
1 ml |
Ask for price |
|
Clostridium difficile Toxin A Antibody |
GWB-47BE95 |
GenWay Biotech |
0.1 mg |
Ask for price |
|
Clostridium difficile Antibody (Toxin B) |
GWB-5554A5 |
GenWay Biotech |
1 ml |
Ask for price |
|
Clostridium Difficile Toxin A Antibody |
GWB-595798 |
GenWay Biotech |
0.1 mg |
Ask for price |
Clostridium Difficile Toxin B Antibody |
GWB-2FB8F7 |
GenWay Biotech |
0.1 mg |
Ask for price |
Clostridium difficile toxin B, Antibody |
GWB-176EB0 |
GenWay Biotech |
0.2 mg |
Ask for price |
|
Clostridium difficile toxin B, Antibody |
GWB-17ED1D |
GenWay Biotech |
0.2 mg |
Ask for price |
|
Clostridium difficile Antibody (Toxin A) |
GWB-8A6F10 |
GenWay Biotech |
0.1 mg |
Ask for price |
Clostridium difficile toxin B, Antibody |
GWB-A91789 |
GenWay Biotech |
0.2 mg |
Ask for price |
Clostridium difficile toxin B, Antibody |
GWB-A93A10 |
GenWay Biotech |
0.2 mg |
Ask for price |
Clostridium Difficile Toxin A Antibody |
GWB-6CA747 |
GenWay Biotech |
1 ml |
Ask for price |
Clostridium difficile Toxin B Antibody |
GWB-7E901E |
GenWay Biotech |
0.5 ml |
Ask for price |
Clostridium difficile toxin A, Antibody |
GWB-F89686 |
GenWay Biotech |
0.2 mg |
Ask for price |
Clostridium difficile Antibody (Toxin A) |
GWB-F0E748 |
GenWay Biotech |
1 mg |
Ask for price |
Clostridium difficile Antibody (Toxin B) |
GWB-D29B29 |
GenWay Biotech |
1 mg |
Ask for price |
Clostridium Difficile Toxin A Antibody |
GWB-D320AC |
GenWay Biotech |
0.1 mg |
Ask for price |
Clostridium difficile Antibody (Toxin A) |
GWB-D3263D |
GenWay Biotech |
0.1 mg |
Ask for price |
Clostridium Difficile Toxin B Antibody |
GWB-DD9B3B |
GenWay Biotech |
0.1 mg |
Ask for price |
Clostridium difficile toxin A, Antibody |
GWB-BE66E0 |
GenWay Biotech |
0.2 mg |
Ask for price |
Clostridium difficile Toxin A Antibody |
V8285-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: This mAb reacts with C. difficile Toxin A, but not with Cholera subunit a, Cholera toxin, Pseudomonas aeruginosa exotoxin A, H-LT, P-LT. Clostridium difficile is a major nosocomial pathogen that causes antibiotic- associated colitis. Clostridium difficile mediates inflammatory diarrhea by releasing two large protein enterotoxins (Toxin A and Toxin B) that are able to disrupt intestinal epithelial cells via their transferase activity and ability to monoglucosylate members of the Rho family. Clostridium difficile Toxin A is a toxin that is composed of 39 repeats that are responsible for binding to intestinal epithelial cell surface carbohydrates. Clostridium difficile Toxin A causes significant apoptosis of colonocytes which contributes to the formation of ulcers and pseudo-membranes in a pathway that involves p38-dependent activation of p53 and induction of p21, leading to cytochrome c release and caspase-3 activation through Bak activation. |
Clostridium difficile Toxin A Antibody |
V8285-20UG |
NSJ Bioreagents |
20 ug |
EUR 186.15 |
|
Description: This mAb reacts with C. difficile Toxin A, but not with Cholera subunit a, Cholera toxin, Pseudomonas aeruginosa exotoxin A, H-LT, P-LT. Clostridium difficile is a major nosocomial pathogen that causes antibiotic- associated colitis. Clostridium difficile mediates inflammatory diarrhea by releasing two large protein enterotoxins (Toxin A and Toxin B) that are able to disrupt intestinal epithelial cells via their transferase activity and ability to monoglucosylate members of the Rho family. Clostridium difficile Toxin A is a toxin that is composed of 39 repeats that are responsible for binding to intestinal epithelial cell surface carbohydrates. Clostridium difficile Toxin A causes significant apoptosis of colonocytes which contributes to the formation of ulcers and pseudo-membranes in a pathway that involves p38-dependent activation of p53 and induction of p21, leading to cytochrome c release and caspase-3 activation through Bak activation. |
Clostridium difficile Toxin A Antibody |
V8285SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 424.15 |
|
Description: This mAb reacts with C. difficile Toxin A, but not with Cholera subunit a, Cholera toxin, Pseudomonas aeruginosa exotoxin A, H-LT, P-LT. Clostridium difficile is a major nosocomial pathogen that causes antibiotic- associated colitis. Clostridium difficile mediates inflammatory diarrhea by releasing two large protein enterotoxins (Toxin A and Toxin B) that are able to disrupt intestinal epithelial cells via their transferase activity and ability to monoglucosylate members of the Rho family. Clostridium difficile Toxin A is a toxin that is composed of 39 repeats that are responsible for binding to intestinal epithelial cell surface carbohydrates. Clostridium difficile Toxin A causes significant apoptosis of colonocytes which contributes to the formation of ulcers and pseudo-membranes in a pathway that involves p38-dependent activation of p53 and induction of p21, leading to cytochrome c release and caspase-3 activation through Bak activation. |
Clostridium difficile Toxin A Antibody |
abx120033-100l |
Abbexa |
100 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx120033-20l |
Abbexa |
20 µl |
EUR 1250 |
Clostridium difficile Toxin A Antibody |
abx120033-50l |
Abbexa |
50 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx120034-100l |
Abbexa |
100 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx120034-20l |
Abbexa |
20 µl |
EUR 1175 |
Clostridium difficile Toxin A Antibody |
abx120034-50l |
Abbexa |
50 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx120036-100l |
Abbexa |
100 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx120036-20l |
Abbexa |
20 µl |
EUR 950 |
Clostridium difficile Toxin B Antibody |
abx120036-50l |
Abbexa |
50 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx021624-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx021624-80l |
Abbexa |
80 µl |
EUR 1550 |
Clostridium difficile Toxin A Antibody |
abx021625-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx021625-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin A Antibody |
abx021626-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx021626-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin A Antibody |
abx021627-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin A Antibody |
abx021627-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin B Antibody |
abx021628-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx021628-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin B Antibody |
abx021629-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx021629-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin B Antibody |
abx021630-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx021630-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin B Antibody |
abx021631-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx021631-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin B Antibody |
abx021632-400l |
Abbexa |
400 µl |
Ask for price |
Clostridium difficile Toxin B Antibody |
abx021632-80l |
Abbexa |
80 µl |
EUR 1200 |
Clostridium difficile Toxin A Mouse mAb |
E2210010-1G3 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Clostridium difficile Toxin A Mouse mAb |
E2210010-2D4 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Just one sexually reproducing native species was detected. Triploid and pentaploid states help our speculation that the kind of apomixis in Hanguana is gametophytic. Inhabitants genomics instruments provide a fast and cost-effective manner of detecting extra clonality and thereby inferring apomixis. Within the case of Hanguana, the presence of male vegetation is a powerful indicator of sexual replica, whereas genome triplication is indicative of apomictic replica.